BE899278A - Agent antimycotique a haute liberation de substance active sous forme d'une creme. - Google Patents

Agent antimycotique a haute liberation de substance active sous forme d'une creme.

Info

Publication number
BE899278A
BE899278A BE0/212659A BE212653A BE899278A BE 899278 A BE899278 A BE 899278A BE 0/212659 A BE0/212659 A BE 0/212659A BE 212653 A BE212653 A BE 212653A BE 899278 A BE899278 A BE 899278A
Authority
BE
Belgium
Prior art keywords
active substance
cream
release
antimycotic agent
agent
Prior art date
Application number
BE0/212659A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE899278A publication Critical patent/BE899278A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Des crèmes qui contiennent du Bifonazol comme substance active avec 10-60% d'un agent d'étendage et 20-80% d'un solvant, exercent une bonne activité antimycotique et peuvent etre utilisées comme médicaments.
BE0/212659A 1983-03-30 1984-03-29 Agent antimycotique a haute liberation de substance active sous forme d'une creme. BE899278A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (1)

Publication Number Publication Date
BE899278A true BE899278A (fr) 1984-10-01

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212659A BE899278A (fr) 1983-03-30 1984-03-29 Agent antimycotique a haute liberation de substance active sous forme d'une creme.

Country Status (19)

Country Link
JP (1) JPS59184106A (fr)
KR (1) KR840008284A (fr)
AU (1) AU564956B2 (fr)
BE (1) BE899278A (fr)
CA (1) CA1212327A (fr)
CH (1) CH660126A5 (fr)
CY (1) CY1358A (fr)
DE (1) DE3311701A1 (fr)
ES (3) ES8503947A1 (fr)
FR (1) FR2543435B1 (fr)
GB (1) GB2137091B (fr)
GR (1) GR81485B (fr)
IT (1) IT1173761B (fr)
KE (1) KE3704A (fr)
LU (1) LU85271A1 (fr)
PH (1) PH20420A (fr)
PT (1) PT78313B (fr)
SE (1) SE8401748L (fr)
ZA (1) ZA842337B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
ES539290A0 (es) 1985-11-16
GB2137091A (en) 1984-10-03
ES8601693A1 (es) 1985-11-16
CH660126A5 (de) 1987-03-31
DE3311701A1 (de) 1984-10-04
AU2623684A (en) 1984-10-04
IT8420303A0 (it) 1984-03-29
SE8401748D0 (sv) 1984-03-29
FR2543435A1 (fr) 1984-10-05
ES8601692A1 (es) 1985-11-16
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
FR2543435B1 (fr) 1988-06-17
SE8401748L (sv) 1984-10-01
CA1212327A (fr) 1986-10-07
ES539289A0 (es) 1985-11-16
PH20420A (en) 1987-01-05
KE3704A (en) 1987-03-27
GB2137091B (en) 1986-10-01
CY1358A (en) 1987-08-07
ES530846A0 (es) 1985-04-16
LU85271A1 (de) 1984-11-14
AU564956B2 (en) 1987-09-03
PT78313A (en) 1984-04-01
GB8408067D0 (en) 1984-05-10
GR81485B (fr) 1984-12-11
IT1173761B (it) 1987-06-24
JPS59184106A (ja) 1984-10-19
ES8503947A1 (es) 1985-04-16
KR840008284A (ko) 1984-12-14

Similar Documents

Publication Publication Date Title
MY100359A (en) External pharmaceutical composition.
JPS5312844A (en) Nn44halogenobenzyllnnmethyl*or nonsubstitutedd*cycloalkylln**phenylurea or thiourea compounds* their preparation and fungicides containing the same as active constituents
PT74703A (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
IT7928417A0 (it) Composizioni farmaceutiche con esaltazione dell'attivita'terapeutica di cortisonici.
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
EP0136914A3 (fr) Compositions de shampooing
NL7903400A (nl) Werkwijze voor de bereiding van alpha,beta-onverzadigde n-gesubstitueerde carbonzuuramiden.
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
IL48238A (en) N-(4-halobenzyl)-n-sec.alkyln'-phenylureas,their preparation and fungicidal compositions containing them
NO941097D0 (no) Hudregenererende kosmetisk preparat
BE899278A (fr) Agent antimycotique a haute liberation de substance active sous forme d'une creme.
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
BE899277A (fr) Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
IT8121960A0 (it) Composti ad attivita' gaba simile, procedimento per prepararli e composizioni farmaceutiche cheli comprendono.
IT8222873A0 (it) Composti steroidei ad attivita'coleretica, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo.
HK45984A (en) Compositions containing n-(2-amino-3,5-dibromobenzyl)-n-methyl-cyclohexylamine and/or its salts
IT8319401A0 (it) Peptide e agente ormonale contenente lo stesso come ingrediente attivo.
JPS53133207A (en) Liquid shampoo composition
IT8421627A0 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo.
IT8222339A0 (it) Composti ad attivita'calcio-antagonista, metodo per laloro preparazione e composizioni farmaceutiche.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BAYER A.G.

Effective date: 20040329